Diagnostic Potential of Supplemental Static and Dynamic ⁶⁸ Ga-FAPI-46 PET for Primary ¹⁸ F-FDG-Negative Pulmonary Lesions.

Autor: Röhrich M; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany; manuel.roehrich@med.uni-heidelberg.de.; Department of Nuclear Medicine, University Hospital Mainz, Mainz, Germany.; German Center of Lung Research, Heidelberg, Germany., Daum J; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; German Center of Lung Research, Heidelberg, Germany., Gutjahr E; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Spektor AM; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; German Center of Lung Research, Heidelberg, Germany., Glatting FM; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Molecular and Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany., Sahin YA; Department of Nuclear Medicine, University Hospital Mainz, Mainz, Germany., Buchholz HG; Department of Nuclear Medicine, University Hospital Mainz, Mainz, Germany., Hoppner J; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; German Center of Lung Research, Heidelberg, Germany., Schroeter C; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; German Center of Lung Research, Heidelberg, Germany., Mavriopoulou E; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; German Center of Lung Research, Heidelberg, Germany., Schlamp K; German Center of Lung Research, Heidelberg, Germany.; Department of Radiology, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany., Grott M; German Center of Lung Research, Heidelberg, Germany.; Department of Thoracic Surgery, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany., Eichhorn F; German Center of Lung Research, Heidelberg, Germany.; Department of Thoracic Surgery, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany., Heußel CP; German Center of Lung Research, Heidelberg, Germany.; Department of Radiology, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany., Kauczor HU; German Center of Lung Research, Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.; Center for Interstitial and Rare Lung Diseases, Pneumology, and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany., Kreuter M; Department of Pneumology, Mainz Center for Pulmonary Medicine, Mainz University, Mainz, Germany.; Medical Center and Department of Pulmonary, Critical Care, and Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany., Giesel F; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; German Center of Lung Research, Heidelberg, Germany.; Department of Nuclear Medicine, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany.; Institute for Radiation Sciences, Osaka University, Osaka, Japan.; German Cancer Consortium, Heidelberg, Germany; and., Schreckenberger M; Department of Nuclear Medicine, University Hospital Mainz, Mainz, Germany., Winter H; German Center of Lung Research, Heidelberg, Germany.; Department of Radiology, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany., Haberkorn U; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; German Center of Lung Research, Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Jun 03; Vol. 65 (6), pp. 872-879. Date of Electronic Publication: 2024 Jun 03.

Comparison of early and late ⁶⁸ Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas.

Autor: Hoppner J; Department of Nuclear Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., van Genabith L; Department of Nuclear Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Hielscher T; Department of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Heger U; Department of General, Visceral, and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany., Sperling L; Department of General, Visceral, and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany., Colbatzky T; Department of General, Visceral, and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany., Gutjahr E; Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Lang M; Department of General, Visceral, and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany., Pausch T; Department of General, Visceral, and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany., Spektor AM; Department of Nuclear Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Glatting FM; Clinical Cooperation Unit Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Liermann J; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany., Hackert T; Department of General, Visceral, and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany., Kratochwil C; Department of Nuclear Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Giesel FL; Department of Nuclear Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Department of Nuclear Medicine, University Hospital Düsseldorf, Düsseldorf, Germany., Haberkorn U; Department of Nuclear Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany., Röhrich M; Department of Nuclear Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. manuel.roehrich@med.uni-heidelberg.de.; Department of Nuclear Medicine, University Hospital Mainz, Langenbeckstraße 1, 55131, Mainz, Germany. manuel.roehrich@med.uni-heidelberg.de.

Publikováno v: Scientific reports [Sci Rep] 2023 Oct 19; Vol. 13 (1), pp. 17848. Date of Electronic Publication: 2023 Oct 19.

Repetitive Early ⁶⁸ Ga-FAPI PET Acquisition Comparing ⁶⁸ Ga-FAPI-02, ⁶⁸ Ga-FAPI-46, and ⁶⁸ Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions.

Autor: Glatting FM; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Molecular and Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany., Hoppner J; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology, University of Heidelberg, Heidelberg, Germany., Liew DP; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., van Genabith A; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Spektor AM; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Steinbach L; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Hubert A; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Kratochwil C; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Giesel FL; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; Department of Nuclear Medicine, University Hospital Düsseldorf, Düsseldorf, Germany., Dendl K; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Rathke H; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Kauczor HU; Department of Diagnostic and Interventional Radiology, University of Heidelberg, Heidelberg, Germany.; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research DZL, Heidelberg, Germany; and., Huber PE; Clinical Cooperation Unit Molecular and Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany., Haberkorn U; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research DZL, Heidelberg, Germany; and.; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany., Röhrich M; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany; manuel.roehrich@med.uni-heidelberg.de.; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research DZL, Heidelberg, Germany; and.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Dec; Vol. 63 (12), pp. 1844-1851. Date of Electronic Publication: 2022 May 26.

Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study.

Autor: Röhrich M; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany; manuel.roehrich@med.uni-heidelberg.de., Leitz D; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research DZL, Heidelberg, Germany., Glatting FM; Clinical Cooperation Unit Molecular and Radiation Oncology, German Cancer Research Center, Heidelberg, Germany., Wefers AK; Department of Neuropathology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany., Weinheimer O; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research DZL, Heidelberg, Germany., Flechsig P; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Kahn N; Centre for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thorax Clinic, University of Heidelberg, Heidelberg, Germany; and., Mall MA; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research DZL, Heidelberg, Germany., Giesel FL; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Kratochwil C; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Huber PE; Clinical Cooperation Unit Molecular and Radiation Oncology, German Cancer Research Center, Heidelberg, Germany., Deimling AV; Department of Neuropathology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany., Heußel CP; Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany., Kauczor HU; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research DZL, Heidelberg, Germany., Kreuter M; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research DZL, Heidelberg, Germany., Haberkorn U; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Jan; Vol. 63 (1), pp. 127-133. Date of Electronic Publication: 2021 Jul 16.